TCRR
Dimensional Fund Advisors’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-171,214
| Closed | -$257K | – | 3551 |
|
|
2023
Q1 | $257K | Sell |
171,214
-38,904
| -19% | -$58.3K | ﹤0.01% | 3157 |
|
|
2022
Q4 | $209 | Sell |
210,118
-117,830
| -36% | -$117 | ﹤0.01% | 3220 |
|
|
2022
Q3 | $590K | Buy |
327,948
+196,555
| +150% | +$354K | ﹤0.01% | 3008 |
|
|
2022
Q2 | $381K | Buy |
131,393
+7,442
| +6% | +$21.6K | ﹤0.01% | 3124 |
|
|
2022
Q1 | $342K | Sell |
123,951
-2,585
| -2% | -$7.13K | ﹤0.01% | 3228 |
|
|
2021
Q4 | $590K | Sell |
126,536
-10,647
| -8% | -$49.6K | ﹤0.01% | 3132 |
|
|
2021
Q3 | $1.17M | Sell |
137,183
-308,632
| -69% | -$2.63M | ﹤0.01% | 3010 |
|
|
2021
Q2 | $7.32M | Buy |
445,815
+95,131
| +27% | +$1.56M | ﹤0.01% | 2481 |
|
|
2021
Q1 | $7.74M | Buy |
350,684
+236,154
| +206% | +$5.21M | ﹤0.01% | 2426 |
|
|
2020
Q4 | $3.54M | Buy |
114,530
+68,839
| +151% | +$2.13M | ﹤0.01% | 2640 |
|
|
2020
Q3 | $926K | Buy |
+45,691
| New | +$926K | ﹤0.01% | 2952 |
|